단백질 시퀀싱 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of protein sequencing Market

The global protein sequencing market size was valued at USD 2.29 billion in 2025 and is projected to grow from USD 2.39 billion in 2026 to USD 3.45 billion by 2034, exhibiting a CAGR of 4.72% during the forecast period. North America dominated the global protein sequencing market with a 41.48% market share in 2025. Increasing demand for detailed protein characterization, advancements in analytical technologies, rising pharmaceutical and biotechnology research, and growing applications in biomarker discovery and personalized medicine are supporting market expansion. Protein sequencing technologies are increasingly used for therapeutic protein characterization, drug discovery, proteomics research, and biological analysis.

Market Dynamics

Market Drivers

Rising Demand for Protein Therapeutics to Drive Market Growth

The growing development and adoption of protein-based therapeutics are increasing demand for advanced sequencing technologies. The rising prevalence of cancer, cardiovascular disorders, genetic diseases, and other chronic conditions is encouraging pharmaceutical and biotechnology companies to conduct detailed protein analysis. Increasing research funding and the development of biologics are further supporting market growth.

Market Restraints

High Cost of Protein Sequencing Equipment to Limit Adoption

Advanced protein sequencing instruments, including mass spectrometers and next-generation sequencing systems, require significant capital investment. High equipment costs can restrict adoption among small biotechnology companies, academic institutions, and research laboratories. Complex maintenance requirements and associated operational expenses can further limit accessibility.

Market Opportunities

Increasing Research Funding Creates New Growth Opportunities

Growing investments in proteomics and biotechnology research are creating opportunities for protein sequencing companies. Funding for single-molecule sequencing, nanopore technologies, automation, and advanced analytical platforms is encouraging companies to introduce affordable and reproducible sequencing solutions.

Market Trends

Automation and AI Integration Transform Protein Sequencing Workflows

Automation, artificial intelligence, and workflow integration are emerging as important trends. AI-enabled platforms can improve sequencing efficiency, analytical accuracy, and data interpretation while automated systems reduce manual intervention and processing time. These technologies are supporting the development of higher-throughput protein analysis solutions.

Market Challenges

Limited Availability of Skilled Professionals Challenges Market Expansion

The market faces challenges due to the limited availability of professionals skilled in operating sophisticated sequencing instruments, mass spectrometry systems, proteomics workflows, and bioinformatics platforms. Training requirements and technical complexity can slow adoption, particularly among smaller research organizations.

Segmentation Analysis

By Product & Services

The market is segmented into instruments, reagents & consumables, and software and services. The reagents & consumables segment dominated in 2025, supported by recurring demand for sequencing kits, laboratory reagents, and consumable products used in proteomics and drug development. The instruments segment is expected to grow steadily through 2034.

By Technology

The market includes mass spectrometry, Edman degradation, next-generation sequencing, and others. Mass spectrometry accounted for 80.8% of the market in 2025, supported by its high sensitivity, accuracy, and ability to analyze complex protein samples. Next-generation sequencing is expected to witness strong growth as new protein sequencing platforms are commercialized.

By Application

Applications include biotherapeutics & biologics characterization, proteomics & biomarker discovery, drug discovery & target validation, genetic engineering & synthetic biology, and others. Biotherapeutics & biologics characterization held 44.7% of the market in 2025, driven by increasing analysis of monoclonal antibodies, fusion proteins, and biosimilars.

By End User

The market covers pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, and others. Pharmaceutical & biotechnology companies accounted for 49.8% in 2025, supported by increasing investments in therapeutic protein development and clinical research.

Regional Outlook

North America

North America held the leading position with a market value of USD 0.95 billion in 2025 and is projected to reach USD 0.98 billion in 2026. Strong biotechnology infrastructure, research investments, and major industry participants support regional growth. The U.S. market was valued at USD 0.88 billion in 2025.

Europe

Europe was the second-largest region, with a market value of USD 0.62 billion in 2025. Increasing proteomics research, pharmaceutical development, and technological advancements are supporting demand.

Asia Pacific

Asia Pacific was valued at USD 0.55 billion in 2025, making it the third-largest region. Expanding biotechnology capabilities and research investments in China, India, and Japan are supporting growth.

Rest of the World

Latin America and the Middle East & Africa are expected to experience moderate growth as research infrastructure expands and leading companies increase their presence in emerging markets.

Competitive Landscape

The competitive landscape includes major companies such as Thermo Fisher Scientific Inc., Merck KGaA, Agilent, Shimadzu Corporation, Bruker Corporation, Waters Corporation, Bio-Rad Laboratories, SCIEX, Quantum-Si Inc., and Illumina, Inc. Companies are focusing on automation, advanced sequencing platforms, new product launches, collaborations, and strategic expansion to strengthen their market positions.

Key Industry Developments

Recent developments include Quantum-Si expanding next-generation protein sequencing distribution, SCIEX introducing advanced mass spectrometry systems, Agilent collaborating on protein-footprinting technologies, and Bruker advancing four-dimensional proteomics platforms. These developments are improving sequencing capabilities and expanding applications across pharmaceutical and research environments.

Investment Analysis and Opportunities

Increasing investments in proteomics, biologics, personalized medicine, and single-molecule sequencing are creating attractive opportunities for market participants. Funding toward AI-enabled sequencing, automation, and cost-efficient platforms is expected to encourage innovation through 2034.

Conclusion

The global protein sequencing market is expanding from USD 2.29 billion in 2025 to USD 2.39 billion in 2026 and is projected to reach USD 3.45 billion by 2034. Growth will be supported by increasing protein therapeutic development, expanding proteomics research, technological innovation, automation, and rising investments in advanced sequencing platforms. North America will remain an important market, while Asia Pacific is expected to benefit from expanding biotechnology and research capabilities.

Segmentation By Product & Services

• Instruments
• Reagents & Consumables
• Software and Services

By Technology

• Mass Spectrometry
• Edman Degradation
• Next Generation Sequencing
• Others

By Application

• Biotherapeutics & Biologics Characterization
• Proteomics & Biomarker Discovery
• Drug Discovery & Target Validation
• Genetic Engineering & Synthetic Biology
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• CROs & CDMOs
• Academic & Research Institutes
• Others

By Geography

• North America (By Product & Services, Technology, Application, End User, and Country)
  • U.S.
  • Canada
• Europe (By Product & Services, Technology, Application, End User, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product & Services, Technology, Application, End User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product & Services, Technology, Application, End User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product & Services, Technology, Application, End User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Research Scope

• 1.1. Market Segmentation
• 1.2. Research Methodology
• 1.3. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview: Application Areas of Protein Sequencing
• 4.2. Overview: Technological Advancements In Protein Sequencing Techniques
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.4. New Product Launches

5. Global Protein Sequencing Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product & Services
  • 5.1.1. Instruments
  • 5.1.2. Reagents & Consumables
  • 5.1.3. Software and Services
• 5.2. Market Analysis, Insights and Forecast - By Technology
  • 5.2.1. Mass Spectrometry
  • 5.2.2. Edman Degradation
  • 5.2.3. Next Generation Sequencing
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Biotherapeutics & Biologics Characterization
  • 5.3.2. Proteomics & Biomarker Discovery
  • 5.3.3. Drug Discovery & Target Validation
  • 5.3.4. Genetic Engineering & Synthetic Biology
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Pharmaceutical & Biotechnology Companies
  • 5.4.2. CROs & CDMOs
  • 5.4.3. Academic & Research Institutes
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Protein Sequencing Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product & Services
  • 6.1.1. Instruments
  • 6.1.2. Reagents & Consumables
  • 6.1.3. Software and Services
• 6.2. Market Analysis, Insights and Forecast - By Technology
  • 6.2.1. Mass Spectrometry
  • 6.2.2. Edman Degradation
  • 6.2.3. Next Generation Sequencing
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Biotherapeutics & Biologics Characterization
  • 6.3.2. Proteomics & Biomarker Discovery
  • 6.3.3. Drug Discovery & Target Validation
  • 6.3.4. Genetic Engineering & Synthetic Biology
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Pharmaceutical & Biotechnology Companies
  • 6.4.2. CROs & CDMOs
  • 6.4.3. Academic & Research Institutes
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Protein Sequencing Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product & Services
  • 7.1.1. Instruments
  • 7.1.2. Reagents & Consumables
  • 7.1.3. Software and Services
• 7.2. Market Analysis, Insights and Forecast - By Technology
  • 7.2.1. Mass Spectrometry
  • 7.2.2. Edman Degradation
  • 7.2.3. Next Generation Sequencing
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Biotherapeutics & Biologics Characterization
  • 7.3.2. Proteomics & Biomarker Discovery
  • 7.3.3. Drug Discovery & Target Validation
  • 7.3.4. Genetic Engineering & Synthetic Biology
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Pharmaceutical & Biotechnology Companies
  • 7.4.2. CROs & CDMOs
  • 7.4.3. Academic & Research Institutes
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Protein Sequencing Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product & Services
  • 8.1.1. Instruments
  • 8.1.2. Reagents & Consumables
  • 8.1.3. Software and Services
• 8.2. Market Analysis, Insights and Forecast - By Technology
  • 8.2.1. Mass Spectrometry
  • 8.2.2. Edman Degradation
  • 8.2.3. Next Generation Sequencing
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Biotherapeutics & Biologics Characterization
  • 8.3.2. Proteomics & Biomarker Discovery
  • 8.3.3. Drug Discovery & Target Validation
  • 8.3.4. Genetic Engineering & Synthetic Biology
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Pharmaceutical & Biotechnology Companies
  • 8.4.2. CROs & CDMOs
  • 8.4.3. Academic & Research Institutes
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. Japan
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Protein Sequencing Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product & Services
  • 9.1.1. Instruments
  • 9.1.2. Reagents & Consumables
  • 9.1.3. Software and Services
• 9.2. Market Analysis, Insights and Forecast - By Technology
  • 9.2.1. Mass Spectrometry
  • 9.2.2. Edman Degradation
  • 9.2.3. Next Generation Sequencing
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Biotherapeutics & Biologics Characterization
  • 9.3.2. Proteomics & Biomarker Discovery
  • 9.3.3. Drug Discovery & Target Validation
  • 9.3.4. Genetic Engineering & Synthetic Biology
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Pharmaceutical & Biotechnology Companies
  • 9.4.2. CROs & CDMOs
  • 9.4.3. Academic & Research Institutes
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Protein Sequencing Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product & Services
  • 10.1.1. Instruments
  • 10.1.2. Reagents & Consumables
  • 10.1.3. Software and Services
• 10.2. Market Analysis, Insights and Forecast - By Technology
  • 10.2.1. Mass Spectrometry
  • 10.2.2. Edman Degradation
  • 10.2.3. Next Generation Sequencing
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Biotherapeutics & Biologics Characterization
  • 10.3.2. Proteomics & Biomarker Discovery
  • 10.3.3. Drug Discovery & Target Validation
  • 10.3.4. Genetic Engineering & Synthetic Biology
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Pharmaceutical & Biotechnology Companies
  • 10.4.2. CROs & CDMOs
  • 10.4.3. Academic & Research Institutes
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Thermo Fisher Scientific Inc.
  • 11.2.2. Merck KGaA
  • 11.2.3. Agilent
  • 11.2.4. Shimadzu Corporation
  • 11.2.5. Bruker Corporation
  • 11.2.6. Waters Corporation
  • 11.2.7. Bio-Rad Laboratories, Inc.
  • 11.2.8. SCIEX
  • 11.2.9. Quantum-Si Inc.
  • 11.2.10. Illumina, Inc.